logo

For the Inventor, By the Inventor

Schenectady, NY, United States of America

Michael S Adler

This inventor holds 18 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents, primarily in High Voltage Semiconductors. Top assignees: General Electric Company, University System of Maryland, Pacific Bell. Active years: 1981-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael S Adler. Retrieved from https://idiyas.com/inventor/michael-s-adler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18

% Patents Active = 83.3



Average Co-Inventor Count = 2.0

ph-index = 10

Forward Citations = 380(Granted Patents)


Location History:

  • Schenectady, NY (US) (1981 - 1991)
  • Bel Air, MD (US) (2011 - 2015)

Company Filing History:

goldMedal12 out of 52,404 
 
General Electric Company
 patents
silverMedal3 out of 2,029 
 
University System of Maryland
 patents
bronzeMedal2 out of 43 
 
Pacific Bell
 patents
4. 2 out of 8,753 
 
US Government as Represented by the Secretary of the Army
 patents
5. 1 out of 5,097 
 
United States of America as Represented by the Secretary of the Air Force
 patents
where one patent can have more than one assignee

Years Active: 1981-2015

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
High Voltage Integrated Circuits
Power MOSFET Devices
Piezoelectric Switch
Bipolar Transistors
Thyristors
Semiconductor Fabrication
Load Control Circuits
High-Speed Switching
Composite Circuits
JFET Devices
Memory Systems
Latch-Up Prevention
18 patents (USPTO):Explore Patents
1. 9132135 - Method of treating organophosphorous poisoning (2015-09-15),
2. 8703762 - Method of treating organophosphorous poisoning (2014-04-22),
3. 7888346 - Method of treating organophosphorous poisoning (2011-02-15),
4. 5014102 - MOSFET-gated bipolar transistors and thyristors with both turn-on and (1991-05-07),
5. 4963951 - Lateral insulated gate bipolar transistors with improved latch-up (1990-10-16),
6. 4958210 - High voltage integrated circuits (1990-09-18),
7. 4868921 - High voltage integrated circuit devices electrically isolated from an (1989-09-19),
8. 4868620 - High-voltage pull-up device (1989-09-19),
9. 4742263 - Piezoelectric switch (1988-05-03),
10. 4697118 - Piezoelectric switch (1987-09-29),
11. 4663547 - Composite circuit for power semiconductor switching (1987-05-05),
12. 4656493 - Bidirectional, high-speed power MOSFET devices with deep level (1987-04-07),
13. 4593458 - Fabrication of integrated circuit with complementary, (1986-06-10),
14. 4534016 - Beam addressed memory system (1985-08-06),
15. 4494134 - High voltage semiconductor devices comprising integral JFET (1985-01-15),

Title: Michael S Adler: Innovator in Organophosphorus Poisoning Treatment

Introduction

Michael S Adler is a notable inventor based in Schenectady, NY (US). He has made significant contributions to the field of medical treatments, particularly in addressing organophosphorus poisoning. With a total of 18 patents to his name, Adler's work has had a profound impact on both veterinary and human medicine.

Latest Patents

Among his latest patents, Adler has developed a method for treating organophosphorus poisoning. This invention focuses on various methods for treating animals at risk of exposure to organophosphorus compounds. The treatment involves administering a therapeutically effective amount of galantamine or its biologically active analogs. Another patent details a method for treating organophosphorus poisoning in mammals, which also includes administering an OP poisoning-inhibiting amount of galantamine.

Career Highlights

Throughout his career, Michael S Adler has worked with prominent companies such as General Electric Company and Pacific Bell. His experience in these organizations has contributed to his innovative approach to solving complex medical issues.

Collaborations

Adler has collaborated with notable individuals in his field, including James E Kohl and Edson X Albuquerque. These partnerships have likely enhanced his research and development efforts.

Conclusion

Michael S Adler's contributions to the treatment of organophosphorus poisoning exemplify his dedication to innovation in medicine. His patents and collaborations reflect a commitment to improving health outcomes for both animals and humans.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…